Literature DB >> 24687389

Tractable synthesis of multipurpose screening compounds with under-represented molecular features for an open access screening platform.

Felix Wilde1, Edgar Specker, Martin Neuenschwander, Marc Nazaré, Anja Bodtke, Andreas Link.   

Abstract

The layout of multipurpose screening libraries must address criteria for the compounds such as novelty, diversity potential, innovative design, and last but not least synthetic tractability. While academic compound collections are often innovative, novel, and highly divers, synthesis of analogs or larger substance quantities is often hampered by complex multistep syntheses with low overall yields. In addition, covalently binding compounds and interaction motifs designed to bind metal ions were discriminated against by the paradigm that these interaction types must almost inevitably lead to toxic effects. We would like to challenge this hypothesis. The lack of such interactions could be a reason for frequent failure in the disclosure of hits for hitherto undruggable target proteins using commercially available screening collections. Thus, easily synthesizable screening candidates equipped to bind covalently to nucleophiles or to metalloenzymes by chelation are under-represented in public access screening libraries. Within this work, we present the synthesis and deposition of 88 compounds with five distinct functional classes, each of which features under-represented screening motifs, for example, metal ion complexation, reversible covalent binding, or halogen bonding. The collection includes acetohydrazides, acylhydrazones, propylene glycol ethers, 2-cyanoacetamides, and 2-cyanoacrylamides. The rational for the synthesis of most of the compounds was recently published by our group and is now supplemented by additional compounds reported here for the first time. The public access disposition enables academic research groups to collectively expand the druggable space and interdisciplinary collaborate within the scientific field.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24687389     DOI: 10.1007/s11030-014-9518-6

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  28 in total

1.  The X-ray absorption spectroscopic model of the copper(II) imidazole complex ion in liquid aqueous solution: a strongly solvated square pyramid.

Authors:  Patrick Frank; Maurizio Benfatto; Britt Hedman; Keith O Hodgson
Journal:  Inorg Chem       Date:  2012-02-08       Impact factor: 5.165

Review 2.  The resurgence of covalent drugs.

Authors:  Juswinder Singh; Russell C Petter; Thomas A Baillie; Adrian Whitty
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

3.  Investigating the selectivity of metalloenzyme inhibitors.

Authors:  Joshua A Day; Seth M Cohen
Journal:  J Med Chem       Date:  2013-10-14       Impact factor: 7.446

4.  Arylcyanoacrylamides as inhibitors of the Dengue and West Nile virus proteases.

Authors:  Christoph Nitsche; Christian Steuer; Christian D Klein
Journal:  Bioorg Med Chem       Date:  2011-10-25       Impact factor: 3.641

5.  New Cu(II), Co(II), Ni(II) complexes with aroyl-hydrazone based ligand. Synthesis, spectroscopic characterization and in vitro antibacterial evaluation.

Authors:  Madalina Veronica Angelusiu; Stefania-Felicia Barbuceanu; Constantin Draghici; Gabriela Laura Almajan
Journal:  Eur J Med Chem       Date:  2010-01-25       Impact factor: 6.514

6.  Synthesis, electronic and ESR spectral studies on copper(II) nitrate complexes with some acylhydrazines and hydrazones.

Authors:  Vinod P Singh
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2007-11-21       Impact factor: 4.098

7.  Lead optimization of an acylhydrazone scaffold possessing antiviral activity against Lassa virus.

Authors:  James R Burgeson; Dima N Gharaibeh; Amy L Moore; Ryan A Larson; Sean M Amberg; Tove' C Bolken; Dennis E Hruby; Dongcheng Dai
Journal:  Bioorg Med Chem Lett       Date:  2013-09-05       Impact factor: 2.823

8.  Neuroprotective effect of AG490 in experimental traumatic brain injury of rats.

Authors:  Ai-ling DU; Tai-ling Ji; Bin Yang; Jian-feng Cao; Xing-guang Zhang; Yu Li; Shun Pan; Bo Zhang; Zhen-bo Hu; Xian-wei Zeng
Journal:  Chin Med J (Engl)       Date:  2013       Impact factor: 2.628

9.  In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione derivatives.

Authors:  Tashfeen Akhtar; Shahid Hameed; Najim A Al-Masoudi; Roberta Loddo; Paolo La Colla
Journal:  Acta Pharm       Date:  2008-06       Impact factor: 2.230

10.  Evaluation of (S)- and (R)-misonidazole as GPX inhibitors: synthesis, characterization including circular dichroism and in vitro testing on bovine GPx-1.

Authors:  Felix Wilde; Chamseddin Chamseddin; Heidi Lemmerhirt; Patrick J Bednarski; Thomas Jira; Andreas Link
Journal:  Arch Pharm (Weinheim)       Date:  2013-12-27       Impact factor: 3.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.